TREATMENT DISCONTINUATION FOR BIOSIMILAR VERSUS ORIGINATOR IN INFLIXIMAB INITIATORS

Marina Birck  1     Luck Lukusa  1     harminder singh  2     Waqqas Afif  3     Neeraj Narula  4     Yvette Leung  5     Sasha Bernatsky  5    
1 Research Institute of the McGill University Health Centre, Montreal, Canada
2 University of Manitoba, Winnipeg, Canada
3 McGill University Health Center, Montreal, Canada
4 McMaster University, Hamilton, Canada
5 University of British Columbia, Vancouver, Canada

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing